Nykredit A S bought a new position in shares of McKesson Corporation (NYSE:MCK – Free Report) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 57,297 shares of the company’s stock, valued at approximately $43,294,000.
Other hedge funds and other institutional investors also recently bought and sold shares of the company. BlackRock Inc. acquired a new position in shares of McKesson during the 2nd quarter worth about $8,156,743,000. Norges Bank purchased a new position in shares of McKesson in the 4th quarter valued at about $1,651,137,000. Bank of America Corp DE acquired a new stake in shares of McKesson during the 2nd quarter worth about $998,896,000. Legal & General Group Plc acquired a new stake in shares of McKesson during the 2nd quarter worth about $656,566,000. Finally, The Manufacturers Life Insurance Company purchased a new stake in McKesson during the second quarter worth approximately $651,462,000. 85.07% of the stock is currently owned by institutional investors and hedge funds.
McKesson Trading Down 0.3%
Shares of MCK stock opened at $921.70 on Friday. The business’s 50 day moving average is $845.27 and its two-hundred day moving average is $842.63. McKesson Corporation has a twelve month low of $682.35 and a twelve month high of $999.00. The company has a market capitalization of $107.46 billion, a P/E ratio of 24.66, a price-to-earnings-growth ratio of 1.84 and a beta of 0.30.
McKesson Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, October 1st. Shareholders of record on Tuesday, September 1st will be given a dividend of $0.94 per share. This represents a $3.76 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date is Tuesday, September 1st. This is an increase from McKesson’s previous quarterly dividend of $0.82. McKesson’s payout ratio is currently 10.06%.
Analysts Set New Price Targets
A number of brokerages recently issued reports on MCK. JPMorgan Chase & Co. lowered their price target on McKesson from $1,107.00 to $1,015.00 and set an “overweight” rating for the company in a report on Friday, May 8th. Morgan Stanley reissued an “overweight” rating on shares of McKesson in a report on Friday, August 7th. Citigroup boosted their price objective on shares of McKesson from $945.00 to $1,000.00 and gave the stock a “buy” rating in a research report on Friday, July 24th. TD Cowen upped their target price on shares of McKesson from $989.00 to $1,006.00 and gave the company a “buy” rating in a report on Thursday, August 6th. Finally, Wells Fargo & Company increased their target price on shares of McKesson from $812.00 to $933.00 and gave the company an “equal weight” rating in a research report on Tuesday, August 11th. Fourteen equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $973.44.
Get Our Latest Research Report on MCK
Insider Buying and Selling at McKesson
In other news, Director Bradley Lerman sold 301 shares of the firm’s stock in a transaction on Monday, August 10th. The shares were sold at an average price of $892.33, for a total value of $268,591.33. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Brian Tyler sold 8,463 shares of McKesson stock in a transaction dated Tuesday, July 7th. The shares were sold at an average price of $793.56, for a total transaction of $6,715,898.28. Following the completion of the sale, the chief executive officer directly owned 5,919 shares in the company, valued at approximately $4,697,081.64. The trade was a 58.84% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 22,156 shares of company stock valued at $17,305,242 in the last 90 days. Company insiders own 0.06% of the company’s stock.
About McKesson
McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.
The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.
Featured Articles
- Five stocks we like better than McKesson
- The Path to $230 Billion: Broadcom Outlines the Next Phase of Its AI Growth Story
- NVIDIA’s Hugging Face Deal Raises a Bigger Question About Its AI Moat Now
- Dropping the Dough: Yum! Brands Strategically Trims the Fat
- These 3 Stock Charts Just Flashed the Dreaded Death Cross Pattern
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.
